Founded in 2012 by pioneers in rapid diagnostics, NG Biotech is a fully integrated diagnostics company specializing in lateral flow technologies.

The company designs, develops, and manufactures innovative diagnostic solutions, with end-to-end control spanning from early research and development through clinical validation and large-scale industrial deployment.

Headquartered and manufacturing in France, NG Biotech operates to the highest standards of clinical performance, quality assurance, and regulatory compliance, serving healthcare systems and partners worldwide.

NG Biotech is advancing the future of diagnostics by addressing critical unmet needs in the detection of antimicrobial resistance, emerging infectious diseases, and women’s health. Through a new generation of rapid, reliable, and multiplex diagnostic tests, the company enables timely, actionable clinical decision-making where it has the greatest impact.